Buy Metformin (MET) in France

The Metformin project, identified by the token symbol MET, is a cryptocurrency initiative operating on the Solana blockchain. The project is led by a team of three medical professionals who possess a background in academic publishing within various scientific journals. The primary mission of the project is to investigate the potential longevity and anti-aging benefits of the pharmaceutical drug metformin through dedicated research efforts. While the drug metformin is traditionally recognized for its efficacy in managing type 2 diabetes, this Web3 project focuses on its potential to influence aging pathways and chronic disease. The project aims to use the decentralized nature of blockchain technology to fund and explore new avenues in longevity science and health extension. By leveraging a Web3 framework, the team seeks to build a community-driven model for scientific inquiry. The MET token serves as the central asset within this ecosystem. According to the project's documentation, the token is intended to support the research project and its related ecological applications. The vision for the project involves establishing partnerships to expand its user base and potentially integrating the token into real-world applications related to health and longevity research. The project maintains an official website and social media presence where it provides access to its whitepaper and roadmap. It is important to note that while the ticker symbol MET is also used by other unrelated decentralized finance protocols on the Solana network, the Metformin project is specifically distinguished by its focus on medical research and the science of human aging. Users typically interact with the token through various decentralized exchanges and supported platforms within the Solana ecosystem. Learn more